Section 503A Traditional Compounding FDA describes Category 2 substances (for 503A) as those with identified safety risks pending evaluation, and the agency does not intend to apply the same enforcement discretion it uses for Category 1
But now, in my practice, I often use subcutaneous BPC 157 injections for patients dealing with soft tissue injuries, especially when healing seems to be dragging or has stalled altogether
Traditional treatments often involve rest, physical therapy, and sometimes surgery
Comment fonctionne le mcanisme d'action du BPC-157
At 10 active days per cycle, the total annual injection commitment at maximum frequency is only 30 days, making it one of the lowest-burden protocols in terms of active treatment time
PRP is made from your own blood, so theres minimal risk of allergic reaction or rejection